SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14C - Additional information statement materials, definitive:
SEC Accession No. 0001193125-23-251678
Filing Date
2023-10-05
Accepted
2023-10-05 17:26:26
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14C d519215ddefa14c.htm DEFA14C 26664
2 GRAPHIC g519215g1006015727717.jpg GRAPHIC 34610
3 GRAPHIC g519215g1006015727911.jpg GRAPHIC 34922
  Complete submission text file 0001193125-23-251678.txt   123812
Mailing Address 245 HAMMERSMITH ROAD, 3RD FLOOR LONDON X0 W6 8PW
Business Address 245 HAMMERSMITH ROAD, 3RD FLOOR LONDON X0 W6 8PW 011-44-0-203-3846700
Orchard Therapeutics plc (Filer) CIK: 0001748907 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: DEFA14C | Act: 34 | File No.: 001-38722 | Film No.: 231312226
SIC: 2836 Biological Products, (No Diagnostic Substances)